IL17A and COVID-19: Furthermore, PBMCs isolated from severe COVID-19 patients at the acute phase of disease produced higher levels of IL-21, IFNγ, IL-4, and IL-17 in response to spike and RBD, than PBMCs from mild patients (Fig. 3e).